Skip to main content
Log in

Allergen Immunotherapy

When is it Useful?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Aalberse RC, Dieges PH, Knul-Bretlova V, Vooren P, Aalbers M, et al. IgG4 as a blocking antibody. Clinical Reviews in Allergy 1: 289–302, 1983

    PubMed  CAS  Google Scholar 

  • Committee on Safety of Medicines. CSM Update: desensitizing vaccines. British Medical Journal 293: 148, 1986

    Google Scholar 

  • Creticos PS, Van Metre TE, Mardiney MR, Rosenberg GL, Norman PS, et al. Dose response of IgE and IgG antibodies during ragweed immunotherapy. Journal of Allergy and Clinical Immunology 73: 94–104, 1984

    Article  PubMed  CAS  Google Scholar 

  • Dreborg S, et al. Immunotherapy (hyposensitization) and bronchial asthma. Baillière’s Clinical Immunology and Allergy 2: 245–258, 1988

    Google Scholar 

  • Editorial. Unproven procedures for diagnosis and treatment of allergic and immunologic diseases. Position statement by the Executive Committee of the American Academy of Allergy and Immunology. Journal of Allergy and Clinical Immunology 78: 275, 1986

  • Ford RPK, Dawson KP. Is there a place for bee venom desensitization in children? Australian and New Zealand Journal of Medicine 17: 85, 1987

    Article  PubMed  CAS  Google Scholar 

  • Golden DBK, Langlois J, Valentine MD, et al. Treatment failures with whole body extract therapy of insect sting allergy. Journal of the American Medical Association 246: 2460, 1981

    Article  PubMed  CAS  Google Scholar 

  • Golden DBK, Schwartz HJ. Guidelines for venom immunotherapy. Journal of Allergy and Clinical Immunology 77: 727, 1986

    Article  PubMed  CAS  Google Scholar 

  • Grant WB, et al. Does immunotherapy have a role in the treatment of asthma? Clinical Allergy 16: 7–10, 1986

    Article  PubMed  CAS  Google Scholar 

  • Grieco MH. Diagnosis of upper respiratory tract allergy: classical versus controversial. Immunology and Allergy Clinics of North America 7: 1, 1987

    Google Scholar 

  • Lichtenstein LM, et al. Insect allergy: the state of the art. Journal of Allergy and Clinical Immunology 64: 5, 1979

    Article  PubMed  CAS  Google Scholar 

  • Lichtenstein LM, MacGlashan DW. The concept of basophil releasability. Journal of Allergy and Clinical Immunology 77: 291–294, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lichtenstein LM, Norman PS, Winkenwerder WL, Osier AG. In vitro studies of human ragweed allergy: changes in cellular and humoralactivity associated with specific desensitization. Journal of Clinical Investigation 45: 1126, 1966

    Article  PubMed  CAS  Google Scholar 

  • Lockey RF, et al. Fatalities from immunotherapy and skin testing. Journal of Allergy and Clinical Immunology 79: 660, 1987

    Article  PubMed  CAS  Google Scholar 

  • Mailing H-J (Ed.) Immunotherapy. Position paper prepared by the Immunotherapy Subcommittee of the European Academy of Allergology and Clinical Immunology. Allergy 43 (Suppl. 6), 1988

    Google Scholar 

  • Noon L. Prophylactic innoculation against hay fever. Lancet 1: 1572–1573, 1911

    Article  Google Scholar 

  • Nordic Council on Medicines. Registration of Allergen Preparations: Nordic Guidelines, 2nd ed., Uppsala, 1989

  • Norman PS. Why standardized extracts? Journal of Allergy and Clinical Immunology 77: 405, 1985

    Article  Google Scholar 

  • Norman PS, Van Metre TE. The safety of allergenic immunotherapy. Journal of Allergy and Clinical Immunology 85(2): 522–525, 1990

    Article  PubMed  CAS  Google Scholar 

  • Platts-Mills TAE, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. Journal of Allergy and Clinical Immunology 80: 755, 1987

    Article  PubMed  CAS  Google Scholar 

  • Schaeffer M, Sisk LC. Allergenic extracts: a review of their safety and efficacy. Annals of Allergy 52: 2, 1984

    PubMed  CAS  Google Scholar 

  • Tamir R, Castracane JM, Rocklin RE. Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis. Journal of Allergy and Clinical Immunology 79: 591–598, 1987

    Article  PubMed  CAS  Google Scholar 

  • Thompson RA, et al. Current status of allergen immunotherapy: shortened version of a World Health Organization/International Union of Immunological Societies working group report. Lancet 1: 259, 1989

    Google Scholar 

  • Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clinical Allergy 16: 317–322, 1986

    Article  PubMed  CAS  Google Scholar 

  • US Department of Health and Human Services, Food and Drug Administration. Biological products; allergenic extracts; implementations of efficacy review; proposed rule. Federal Register Pt II, 50: 3082, 1985

    Google Scholar 

  • Van Metre TE, Adkinson NF. Immunotherapy for aeroallergen disease. In Middleton et al. (Eds) Allergy: principles and practice, 2nd ed., pp. 1327–1343, CV Mosby Co, St Louis, 1988

    Google Scholar 

  • Warner JO, Kerr JW. Hyposensitization. British Medical Journal 294: 1179, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loblay, R.H. Allergen Immunotherapy. Drugs 40, 493–497 (1990). https://doi.org/10.2165/00003495-199040040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199040040-00002

Keywords

Navigation